Immucor Trading Over 30% Higher after M&A of $27/Share

by Allie Wickman, Benzinga Staff Writer

July 5, 2011 9:46 AM | 13 seconds read | Make a Comment

Immucor, Inc.

BLUD

today announced that it has entered into a definitive agreement to be acquired by investment funds managed by TPG Capital in a transaction with a fully diluted equity value of $1.973 billion. Read more

here

Market News and Data brought to you by Benzinga APIs

Posted In: News M&A Movers Health Care Health Care Supplies

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Immucor Trading Over 30% Higher after M&A of $27/Share